The official Twitter page for McMaster Heart Failure Education. Tweets our own.
Hamilton, Ontario
Joined May 2019
- Tweets6.9K
- Following226
- Followers507
- Likes6K
McMaster Heart Function Education retweeted
This Saturday 9/26, Discover how early detection, preventive therapies, and multidisciplinary care can help reduce the burden of heart failure and improve long-term cardiovascular outcomes. #HeartFailure #CVPrev2026 #UPMC #UPitt
ALT Register Here: https://cce.upmc.com/inaugural-center-cardiovascular-disease-prevention-symposium-innovating-prevention-precision#group-tabs-node-course-default7
McMaster Heart Function Education retweeted
Efficacy and Safety of #Semaglutide According to Frailty Status
A Post Hoc Analysis of the #SELECT Trial
jamanetwork.com/journals/jam… @JAMA_current @JAMACardio
McMaster Heart Function Education retweeted
Now in @JACCJournals #JACCHF, new work from the Donor Heart Study on classification of donors with LVH, opportunities to reclassify using geometric remodeling, leaving a path forward to accept more donors for listed patients @KiranKhush1 @Stanford_HF
🔗 jacc.org/doi/10.1016/j.jchf.…
McMaster Heart Function Education retweeted
#echofirst
✅ Example of structural valve degeneration (SVD) in bioprosthetic AV (TEE)
✅ SVD leads to intrinsic permanent changes in bioprosthetic valve (Ca+ deposits & wear and tear, usually after 10-15 years)
✅ More common in younger pts
✅ In this example, excessive movement of calcified cusp suggests leaflet tear & prolapse (DD: endocarditis)
✅ Comments on valve function?
✅ Ref: Pibarot P et al, JACC 2022;80(5):545-561
@iamritu
@argulian
@sudarshanballa
@alex1708ander
@NMerke
@echo_batman
@DavidWienerMD
@BryanTanMD
@PWesslyMD
@HeartOTXHeartMD
@purviparwani
McMaster Heart Function Education retweeted
📢Just Published in @CircHF: Special issue dedicated to cardiogenic shock Guest Edited by Dr. David Morrow, MD, MPH.
📖Read the issue here: 🔗ahajournals.org/toc/circhear…
@DrNancySweitzer @AHAScience
McMaster Heart Function Education retweeted
A great question! Left heart filling is not affected too much by respiration except when there is a condition for pulsus paradoxus such as constriction, COPD, obesity, etc. Even in those conditions, PV flow decreases with inspiration, but I am not sure how much S/D changes.
McMaster Heart Function Education retweeted
From 3% to 40% five-year cardiovascular risk and BP lowering across every single decile...
At ESC Congress 2026, Prof Kazem Rahimi presented findings from a meta-analysis of ~350,000 participants across 51 randomised trials. Using a cardiovascular risk prediction model, the population was divided into 10 risk groups, spanning from near-healthy patients with a 3% five-year event risk, to very high-risk individuals with a 40% probability of a major cardiovascular event within five years.
The landmark result: a 5 mmHg reduction in systolic blood pressure produced a remarkably consistent ~10% relative risk reduction in major cardiovascular events across all 10 deciles.
The full interview with Prof Rahimi, hosted by Dr Harriette Van Spall, is now available radc.life/WPd9I0ra
#ESCCongress2026 #MedEd #Cardiology
McMaster Heart Function Education retweeted
In case you missed it, here are all late-breaking trial results from #ESCCongress
McMaster Heart Function Education retweeted
🫀 Statins for primary prevention: 4 RCTs, 3 decades
AFCAPS→JUPITER→HOPE-3→STAREE
📉 24–44% ↓ major CV events
Even at baseline LDL (108 mg/dL)
No heterogeneity across subgroups in RRR
🟰 Safety ≈ placebo, few exceptions
⚖️ Benefits ≫ risks
💊 cost $30/year
McMaster Heart Function Education retweeted
In this stepped-wedge cluster #RCT of 19🏥s & 67K presentations of chest pain, implementation of a 0/1-hr #hsTpn pathway had non-inferior safety & similar ED LOS as 0/3-hr pathway
Fun discussion on trial methods & challenges of #implementation trials
#PRESC1SE-MI #ESCCongress
🎙️ Dr Van Spall & Dr Jasper Boeddinghaus discuss PRESC1SE-MI from #ESCCongress2026
Implementation of the ESC 0/1-hour pathway achieved:
📊 67,624 patient presentations 📊 Earlier repeat hs-cTn testing (190 min → 86 min) ✅ Non-inferior for death or new type 1 MI 🏥 No reduction in ED length of stay (309 min vs 309 min)
What do these findings mean for implementation of accelerated chest pain pathways in routine practice?
🎥 radcliffecardiology.com/vide…
#Cardiology #CardioTwitter #CardioX #EmergencyMedicine #ACS #NSTEMI #Troponin #ChestPain #ClinicalResearch #EvidenceBasedMedicine #MedEd @HerzstiftungCH
@McMasterU
McMaster Heart Function Education retweeted
#AMUNDSEN international RCT compared strategy of #PCSK9i (#evolocumab) in cath lab + standard care vs standard care alone in 2166 patients w #ACS undergoing PCI.
At 12 mo
⬆️⬆️ in LDL control
↔️ death or CV 🏥
Will it change practice?
Listen to prof Monteluscat #ESCcongress
Can we lower risk after MI by lowering LDL-C earlier?
🎙️ At #ESCCongress2026, Dr Harriette Van Spall speaks with Prof Gilles Montalescot about #AMUNDSEN, a trial evaluating evolocumab before PCI in STEMI and NSTEMI patients.
A fascinating discussion on timing, prevention and the future of ACS care.
🔗 ow.ly/ISZt50ZGRcX
#AcuteMI #ACS #PCI #PCSK9 #Evolocumab #Cardiology #InterventionalCardiology
McMaster Heart Function Education retweeted
Excessive left ventricular trabeculation (#LVET), traditionally viewed as the hallmark of left ventricular non-compaction (#LVNC), is increasingly recognized as a heterogeneous phenotypic trait rather than a distinct cardiomyopathy. This review examines the evolving evidence on its prevalence, imaging characteristics, genetic architecture, and clinical significance across both physiological and pathological conditions. We discuss the mechanisms underlying excessive trabeculation, the potential for overdiagnosis, and whether LVET represents adaptive remodeling, a marker of shared cardiomyopathic substrates, or a phenotypic modifier influencing outcomes (link.springer.com/article/10…). #HREV
McMaster Heart Function Education retweeted
🚨💊 NEW in Nature Medicine: the POLY-HF trial 🫀
A once-daily HF polypill beat enhanced usual care 👇
📈 +3.3 pts LVEF (P=0.039)
🏥 60% ⬇️ HF hospitalizations/ED visits
💪 71% vs 42% on optimal GDMT
✅ 79% vs 54% adherence
🔗 doi.org/10.1038/s41591-026-0…
McMaster Heart Function Education retweeted
Published today, Deprescribing in Patients with Cardiovascular (CV) Disease Experiencing Polypharmacy A Scientific Statement from the American Heart Association. professional.heart.org/en/sc…
Guideline-directed medical therapy in CV care often requires multiple medications across coexisting conditions and comorbidities, making polypharmacy common in routine practice.
📷 Optimal prescribing
✍🏼 @robdeedo @adambress @quin_denfeld @PaulDobesh @ParagGoyalMD
McMaster Heart Function Education retweeted
How should palliative care fit into advanced HF care?
The HeartPal program embedded palliative care within an advanced heart disease service, resulting in earlier referrals, more GoC discussions, fewer late referrals & reduced in-hospital deaths.
bit.ly/3S4btlS
McMaster Heart Function Education retweeted
Although the health-related benefits of higher fitness and exercise training in both healthy individuals and patients with major comorbidities are widely recognized, participation in regular exercise and exercise training (ET) remains underutilized, especially in high-risk individuals. professional.heart.org/en/sc…
Certain high-risk populations, such as those with frailty, stroke, spinal cord injury, rheumatologic conditions, genetic cardiomyopathies, or recipients of advanced heart failure therapies or cardiac implantable electronic devices, warrant special considerations with regard to ET.
✍🏼 @JRGolbus @FrailtyMD
📷 Supporting exercise among high-risk populations.
McMaster Heart Function Education retweeted
What makes a good biomarker for heart failure? Dr @hvanspall and Prof James Januzzi cut to the heart of it: we often force biomarkers to do something they weren't designed for. Watch here: radc.life/Nrwg5fTb
#HeartFailure #Cardiology #Biomarkers #MedEd
McMaster Heart Function Education retweeted
Myth: most patients newly presenting with HFrEF can't tolerate simultaneous, polypill, or rapid-sequence quadruple GDMT because of dangerous hypotension risk
McMaster Heart Function Education retweeted
🆕 expert analysis provides a framework for antihypertensive medication selection in pregnancy and the postpartum period. Get the details: bit.ly/4fmhOCd #Hypertension #CardioObstetrics
